
Targeting RIPK1: Phenylisoxazolidine derivatives with promising anti-inflammatory activity
Inflammatory Researchers at the China Pharmaceutical University have developed a series of highly active receptor-interacting protein kinase 1 (RIPK1) inhibitors with potent anti-inflammatory activity. RIPK1 is a key regulator of necroptosis, a form of …